These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 23506601)

  • 1. Role of adjuvant chemoradiotherapy in treatment of resectable esophageal carcinoma: a meta-analysis.
    Zheng B; Zheng W; Zhu Y; Lin XY; Xu BH; Chen C
    Chin Med J (Engl); 2013 Mar; 126(6):1178-82. PubMed ID: 23506601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can chemotherapy concomitantly delivered with radiotherapy improve survival of patients with resectable rectal cancer? A meta-analysis of literature data.
    Fiorica F; Cartei F; Licata A; Enea M; Ursino S; Colosimo C; Cammà C
    Cancer Treat Rev; 2010 Nov; 36(7):539-49. PubMed ID: 20334979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postoperative adjuvant chemotherapy versus chemoradiotherapy for node-positive esophageal squamous cell carcinoma: a propensity score-matched analysis.
    Wang Q; Lang J; Li T; Peng L; Dai W; Jiang Y; Xie T; Fang Q; Wang Y; Wu L; Cao B; Han Y
    Radiat Oncol; 2020 May; 15(1):119. PubMed ID: 32448253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis of survival benefit with postoperative chemoradiotherapy in patients of lymph node positive esophageal carcinoma.
    Luo H; Cui YY; Zhang JG; Sun YN; Zheng XL; Yang CL; Ye K; Ge H
    Clin Transl Oncol; 2018 Jul; 20(7):889-898. PubMed ID: 29143229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: a meta-analysis.
    Jin HL; Zhu H; Ling TS; Zhang HJ; Shi RH
    World J Gastroenterol; 2009 Dec; 15(47):5983-91. PubMed ID: 20014464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective comparison of surgery alone and chemoradiotherapy with selective surgery in resectable squamous cell carcinoma of the esophagus.
    Ariga H; Nemoto K; Miyazaki S; Yoshioka T; Ogawa Y; Sakayauchi T; Jingu K; Miyata G; Onodera K; Ichikawa H; Kamei T; Kato S; Ishioka C; Satomi S; Yamada S
    Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):348-56. PubMed ID: 19735862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effectiveness of planned esophagectomy after neoadjuvant chemoradiotherapy for advanced esophageal carcinomas.
    Kato H; Fukuchi M; Manda R; Faried A; Takita J; Nakajima M; Miyazaki T; Sohda M; Fukai Y; Masuda N; Tsukada K; Kuwano H
    Anticancer Res; 2004; 24(6):4091-6. PubMed ID: 15736457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II study of use of a single cycle of induction chemotherapy and concurrent chemoradiotherapy containing capecitabine/cisplatin followed by surgery for patients with resectable esophageal squamous cell carcinoma: long-term follow-up data.
    Koo DH; Park SI; Kim YH; Kim JH; Jung HY; Lee GH; Choi KD; Song HJ; Song HY; Shin JH; Cho KJ; Yoon DH; Kim SB
    Cancer Chemother Pharmacol; 2012 Mar; 69(3):655-63. PubMed ID: 21968953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison between radical esophagectomy and definitive chemoradiotherapy in patients with clinical T1bN0M0 esophageal cancer.
    Motoori M; Yano M; Ishihara R; Yamamoto S; Kawaguchi Y; Tanaka K; Kishi K; Miyashiro I; Fujiwara Y; Shingai T; Noura S; Ohue M; Ohigashi H; Nakamura S; Ishikawa O
    Ann Surg Oncol; 2012 Jul; 19(7):2135-41. PubMed ID: 22302264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neoadjuvant chemoradiotherapy for resectable oesophageal and gastro-oesophageal junction cancer--do we need another randomised trial?
    Hingorani M; Crosby T; Maraveyas A; Dixit S; Bateman A; Roy R
    Clin Oncol (R Coll Radiol); 2011 Dec; 23(10):696-705. PubMed ID: 21684129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short term results of neoadjuvant chemoradiotherapy with fluoropyrimidine alone or in combination with oxaliplatin in locally advanced rectal cancer: a meta analysis.
    An X; Lin X; Wang FH; Goodman K; Cai PQ; Kong LH; Fang YJ; Gao YH; Lin JZ; Wan DS; Pan ZZ; Ding PR
    Eur J Cancer; 2013 Mar; 49(4):843-51. PubMed ID: 23063351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemoradiotherapy followed by surgery could improve the efficacy of treatments in patients with resectable esophageal carcinoma.
    Wang F; Wang YM; He W; Li XK; Peng FH; Yang XL; Fan QX
    Chin Med J (Engl); 2013 Aug; 126(16):3138-45. PubMed ID: 23981626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemoradiotherapy alone as the standard treatment of epidermoid esophageal carcinoma.
    Salek R; Tabrizi FV; Bezenjani SE; Saedi HS; Ashkiki MH; Hosainzadeh SM; Mohtashami S
    Oncology; 2011; 81(3-4):214-9. PubMed ID: 22075490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neoadjuvant chemoradiotherapy for advanced esophageal cancer].
    Natsugoe S; Matsumoto M; Okumura H; Uchikado Y; Setoyama T; Kita Y; Arigami T; Uenosono Y; Owaki T; Ishigami S
    Nihon Geka Gakkai Zasshi; 2011 Mar; 112(2):111-6. PubMed ID: 21488344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival.
    Berger AC; Farma J; Scott WJ; Freedman G; Weiner L; Cheng JD; Wang H; Goldberg M
    J Clin Oncol; 2005 Jul; 23(19):4330-7. PubMed ID: 15781882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of surgery and postoperative chemoradiation therapy in patients with lymph node positive esophageal carcinoma.
    Bédard EL; Inculet RI; Malthaner RA; Brecevic E; Vincent M; Dar R
    Cancer; 2001 Jun; 91(12):2423-30. PubMed ID: 11413534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
    Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neoadjuvant chemoradiotherapy could improve survival outcomes for esophageal carcinoma: a meta-analysis.
    Wang DB; Zhang X; Han HL; Xu YJ; Sun DQ; Shi ZL
    Dig Dis Sci; 2012 Dec; 57(12):3226-33. PubMed ID: 22695886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of neoadjuvant chemoradiotherapy on prognosis and surgery for esophageal carcinoma.
    Lv J; Cao XF; Zhu B; Ji L; Tao L; Wang DD
    World J Gastroenterol; 2009 Oct; 15(39):4962-8. PubMed ID: 19842230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of radiotherapy on survival in resectable gastric carcinoma: a meta-analysis of literature data.
    Fiorica F; Cartei F; Enea M; Licata A; Cabibbo G; Carau B; Liboni A; Ursino S; Cammà C
    Cancer Treat Rev; 2007 Dec; 33(8):729-40. PubMed ID: 17935888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.